The quarter materially exceeded the published bar. Quarterly consensus was roughly $0.32 of EPS and $4.76 billion of revenue; Oscar delivered $1.10 of diluted EPS and $4.88 billion of revenue. The operating beat was driven less by top-line upside than by much better underwriting and expense control: MLR fell to 79.2% from 91.1%, while SG&A fell to 14.2% from 18.7% (Financial Highlights; Income Statement; MLR reconciliation).
| Metric | Q2 2026 | Q2 2025 | H1 2026 | H1 2025 | Expectation |
|---|---|---|---|---|---|
| Total revenue | $4.880B | $2.864B | $9.527B | $5.910B | ~$4.76B Q2 consensus |
| Medical loss ratio | 79.2% | 91.1% | 75.0% | 83.0% | — |
| SG&A expense ratio | 14.2% | 18.7% | 14.7% | 17.2% | — |
| Earnings from operations | $388.6M | $(230.5)M | $1.093B | $66.6M | — |
| Net income attributable to Oscar | $361.8M | $(228.4)M | $1.041B | $46.9M | ~$0.32 Q2 EPS consensus |
| Diluted EPS | $1.10 | $(0.89) | $3.16 | $0.17 | ~$0.32 |
| Adjusted EBITDA | $415.3M | $(199.4)M | $1.142B | $129.4M | — |
Guidance was raised where it matters most. Revenue guidance stayed at $18.7 billion-$19.0 billion, so the company did not increase its growth outlook. But the operating-profit range rose from $250 million-$450 million to $500 million-$700 million, while the MLR and SG&A ranges both improved (2026 Financial Guidance Summary). That is a meaningful revision to expected profitability, not merely favorable presentation.
The quality of the earnings beat is strong but not entirely recurring. Oscar attributed the Q2 MLR improvement partly to $164 million of favorable prior-period reserve development (Financial Highlights). The first-half results also benefited from a $3.365 billion increase in payables to CMS, helping produce $4.711 billion of operating cash flow (Cash Flow statement). Those items improve reported earnings and liquidity, but they make the quarter less clean as a measure of steady-state operating performance.
Membership remains the main counterweight. Effectuated membership reached 2.963 million at June 30, up from 2.027 million a year earlier, but below the 3.174 million reported at March 31, 2026 (Effectuated Membership by Offering; prior-quarter filing context). The filing therefore shows sharply better economics per member, while the customer base appears to have contracted sequentially.
Net read: a clear positive reset to the earnings picture. Even after allowing for reserve development and CMS-related working-capital effects, the combination of a large EPS beat, substantially improved loss ratios, lower administrative costs, and a $250 million midpoint increase in full-year operating guidance lands well above what the market was prepared for. The unchanged revenue outlook and sequential membership decline limit the breadth of the improvement, but they do not outweigh the profitability surprise.
Read the original 8-K on SEC EDGAR ↗